The Abu Dhabi Bone Marrow Transplant (AD-BMT©) Program at ADSCC provides an extensive and integrated ecosystem designed for carrying out advanced research and cellular therapy, while ensuring accessibility patients in UAE and the region. Launched in 2020, the AD-BMT© Program was designed as the first comprehensive program to provide autologous and allogeneic hematopoietic stem cells transplant (HSCT) for adults and pediatric patients in the UAE. Conditions include blood cancers, hereditary diseases and autoimmune diseases such as Multiple Sclerosis.

The AD-BMT© Program’s holistic service model includes:

  • High Quality Clinical Care
  • Advanced Research
  • Apheresis/ECP
  • Cell Processing
  • Cryopreservation
  • Manufacturing of Advanced Cell Therapy
  • Bone Marrow Registry

Bone Marrow Transplant also referred to as Hematopoietic Stem Cells Transplantation is a medical procedure performed to replace bone marrow that has been damaged or destroyed by a disease, infection, or chemotherapy. This procedure involves transplanting healthy blood stem cells, which travel to the bone marrow where they produce new blood cells and promote growth of new marrow. At ADSCC, bone marrow transplantation is performed in patients diagnosed with malignant diseases, including leukemia, lymphoma and multiple myeloma.

The main types of hematological cancers for both children and adults are:

  • Leukemia is a cancer of the blood cells. It starts in the bone marrow, where blood cells are made. There are many different types of leukemia, but the most common in children are acute lymphocytic leukemia (ALL) and acute
    myeloid leukemia (AML).
  • Lymphoma is a cancer of the lymph nodes. The lymph nodes are part of the immune system and help fight infection. There are two main types of lymphoma: Hodgkin lymphoma and non-Hodgkin lymphoma.
  • Myelodysplastic syndromes (MDS) are a group of cancers that affect the bone marrow. MDS causes the bone marrow to make abnormal blood cells.
  • Myeloproliferative disorders (MPD) are a group of cancers that affect the bone marrow. MPD causes the bone marrow to make too many blood cells.
  • Multiple myeloma is a cancer of the plasma cells. Plasma cells are a type of white blood cell that helps fight infection. Multiple myeloma causes the plasma cells to grow abnormally and multiply.

In addition, ADSCC’s AD-BMT© program offers Extracorporeal Photopheresis (ECP), the first in the UAE to use this treatment, for Graft-Versus-Host Disease (GvHD). This is a medical complication that can occur after a patient receives a donor’s stem cells or bone marrow transplant.

ADSCC’s AD-BMT© program was awarded as Center of Excellence by the Department of Health – Abu Dhabi in March 2023 for the first time in the UAE.